0

Scleroderma Collection
 1-20 of 79 Articles
Original Research |  18 February 2014
Treatment of Primary Sjögren Syndrome With Rituximab: A Randomized Trial
Valérie Devauchelle-Pensec, MD, PhD; Xavier Mariette, MD, PhD; Sandrine Jousse-Joulin, MD; et al.
Ann Intern Med. 2014;160(4):233-242. doi:10.7326/M13-1085
Original Research |  16 November 2010
Autologous Mesenchymal Stem Cells Foster Revascularization of Ischemic Limbs in Systemic Sclerosis: A Case Report
Serena Guiducci, MD; Francesco Porta, MD; Riccardo Saccardi, MD; et al.
Ann Intern Med. 2010;153(10):650-654. doi:10.7326/0003-4819-153-10-201011160-00007
Editorials |  16 March 2010
Propensity Score Adjustment With Multilevel Data: Setting Your Sites on Decreasing Selection Bias
Michael E. Griswold, PhD; A. Russell Localio, PhD; Cynthia Mulrow, MD, MSc, Senior Deputy Editor
Ann Intern Med. 2010;152(6):393-395. doi:10.7326/0003-4819-152-6-201003160-00010
Reviews |  2 February 2010
Narrative Review: Fibrotic Diseases: Cellular and Molecular Mechanisms and Novel Therapies
Joel Rosenbloom, MD, PhD; Susan V. Castro, PhD; Sergio A. Jimenez, MD
Ann Intern Med. 2010;152(3):159-166. doi:10.7326/0003-4819-152-3-201002020-00007
Reviews |  6 January 2004
Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis
Sergio A. Jimenez, MD; Chris T. Derk, MD
Ann Intern Med. 2004;140(1):37-50. doi:10.7326/0003-4819-140-2-200401200-00013
Articles |  20 June 2000
Cyclophosphamide Is Associated with Pulmonary Function and Survival Benefit in Patients with Scleroderma and Alveolitis
Barbara White, MD; Wendy C. Moore, MD; Fredrick M. Wigley, MD; et al.
Ann Intern Med. 2000;132(12):947-954. doi:10.7326/0003-4819-132-12-200006200-00004
Articles |  6 June 2000
Recombinant Human Relaxin in the Treatment of Scleroderma: A Randomized, Double-Blind, Placebo-Controlled Trial
James R. Seibold, MD; Joseph H. Korn, MD; Robert Simms, MD; et al.
Ann Intern Med. 2000;132(11):871-879. doi:10.7326/0003-4819-132-11-200006060-00004
Articles |  21 March 2000
Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease: A Randomized, Controlled Trial
David B. Badesch, MD; Victor F. Tapson, MD; Michael D. McGoon, MD; et al.
Ann Intern Med. 2000;132(6):425-434. doi:10.7326/0003-4819-132-6-200003210-00002
Ideas and Opinions |  1 January 1995
Modulation of Collagen Gene Expression: Its Relation to Fibrosis in Systemic Sclerosis and Other Disorders
John Varga, MD; Sergio A. Jimenez, MD
Ann Intern Med. 1995;122(1):60-62. doi:10.7326/0003-4819-122-1-199501010-00010
Articles |  1 July 1994
Pulmonary Function and Gastroesophageal Reflux in Systemic Sclerosis
Matthew B. Troshinsky, MD; Gregory C. Kane, MD; John Varga, MD; et al.
Ann Intern Med. 1994;121(1):6-10. doi:10.7326/0003-4819-121-1-199407010-00002
Articles |  1 February 1994
Intravenous Iloprost Infusion in Patients with Raynaud Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Placebo-controlled, Double-Blind Study
Fredrick M. Wigley, MD; Robert A. Wise, MD; James R. Seibold, MD; et al.
Ann Intern Med. 1994;120(3):199-206. doi:10.7326/0003-4819-120-3-199402010-00004
Articles |  15 November 1993
Autoantibody Reactive with RNA Polymerase III in Systemic Sclerosis
Yutaka Okano, MD; Virginia D. Steen, MD; Thomas A. Medsger, MD
Ann Intern Med. 1993;119(10):1005-1013. doi:10.7326/0003-4819-119-10-199311150-00007
Articles |  15 April 1993
Early Undifferentiated Connective Tissue Disease: III. Outcome and Prognostic Indicators in Early Scleroderma (Systemic Sclerosis)
Ken J. Bulpitt, MD; Philip J. Clements, MD; Peter A. Lachenbruch, PhD; et al.
Ann Intern Med. 1993;118(8):602-609. doi:10.7326/0003-4819-118-8-199304150-00005
Articles |  15 September 1991
Natural History of the Eosinophilia-Myalgia Syndrome
Randall C. Culpepper, MD, MPH; Ronald G. Williams, MD, MPH; Philip J. Mease, MD; et al.
Ann Intern Med. 1991;115(6):437-442. doi:10.7326/0003-4819-115-6-437
Letters |  1 April 1991
Iloprost for Scleroderma
Thierry Constans, MD; Elisabeth Diot, MD; Gérard Lasfargues, MD
Ann Intern Med. 1991;114(7):606. doi:10.7326/0003-4819-114-7-606_1
Articles |  1 September 1990
Outcome of Renal Crisis in Systemic Sclerosis: Relation to Availability of Angiotensin Converting Enzyme (ACE) Inhibitors
Virginia D. Steen, MD; Joseph P. Costantino, DrPH; Alvin P. Shapiro, MD; et al.
Ann Intern Med. 1990;113(5):352-357. doi:10.7326/0003-4819-113-5-352
Articles |  15 May 1990
L-Tryptophan Ingestion Associated with Eosinophilic Fasciitis but Not Progressive Systemic Sclerosis
Bruce Freundlich, MD; Victoria P. Werth, MD; Alain H. Rook, MD; et al.
Ann Intern Med. 1990;112(10):758-762. doi:10.7326/0003-4819-112-10-758
Articles |  1 March 1990
Development of Diffuse Fasciitis with Eosinophilia during L-Tryptophan Treatment: Demonstration of Elevated Type I Collagen Gene Expression in Affected Tissues: A Clinicopathologic Study of Four Patients
John Varga, MD; Juha Peltonen, MD, PhD; Jouni Uitto, MD, PhD; et al.
Ann Intern Med. 1990;112(5):344-351. doi:10.7326/0003-4819-112-5-344
Articles |  1 September 1989
Systemic Sclerosis after Augmentation Mammoplasty with Silicone Implants
John Varga, MD; H. Ralph Schumacher, MD; Sergio A. Jimenez, MD
Ann Intern Med. 1989;111(5):377-383. doi:10.7326/0003-4819-111-5-377
Articles |  15 March 1989
Interleukin-2 in Scleroderma: Correlation of Serum Level with Extent of Skin Involvement and Disease Duration
M. Bashar Kahaleh, MD; Carwile E. LeRoy, MD
Ann Intern Med. 1989;110(6):446-450. doi:10.7326/0003-4819-110-6-446
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)